Company News

BEXION to appear on Sky Radio in August (May 2008) NEW!

BEXION partners with Molecular Targeting Technologies (MTTI) on development of tumor diagnostics. April 2008 NEW!

BEXION RECEIVES 2007 PHASE 1 SBIR GRANT R43CA130228-01: "A novel biotherapeutic treatment for prostate cancer" NEW!

BEXION CEO SCHEDULED TO ADDRESS 6th ANNUAL NORTH AMERICA FORUM: INVESTING & PARTNERING IN BIOTECH IN MARCH 2007.  
Bexion's CEO, Dr. Ray Takigiku, to Discuss The New Exciting Tumor-Targeting Data On SapC-DOPS.


BEXION CEO ADDRESSED BIO MID-AMERICA VENTURE FORUM IN SEPTEMBER 2006
CEO to Discuss How Proprietary Platform Anti-Cancer Technology Represents Potential Breakthrough Treatment for Pancreatic Cancer Treatment.